mRNA

Assoc Prof Tim Mercer and researcher Dae Jong Han, UQ
#Australia #Bioproduction #mRNA #Sanofi #TriLink BioTechnologies #United States #University of Queensland

As mRNA demand surges, Australia and US launch new facilities

As demand for mRNA continues to surge, two new facilities have been launched to boost production in Australia and the US. Work is underway at The University of Queensland’s (UQ) BASE facility which has become Australia’s leading provider of mRNA for research and pilot studies since… Read More

#News

In vitro study
#In vitro #IVT #mRNA #Thermo Fisher Scientific #Webinar

Scaling up in vitro transcription: Exclusive free event

Join DDW for this exclusive free event, Scaling up in vitro transcription: Key results and considerations, which is supported by Thermo Fisher Scientific. In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that… Read More

#News

#etherna #mRNA #Novalis

New leadership for mRNA company etherna  

etherna, an mRNA/LNP technologies company, has announced that Bernard Sagaert has been confirmed as Chief Executive Officer. At the same time Marijn Dekkers, an existing Board Member representing investor Novalis LifeSciences LLC, has been appointed Chairman of the Board.  Sagaert’s appointment follows an interim 12-month period during which he has… Read More

#Business & Investment #News

In vitro diagnostics
#In vitro #IVT #mRNA #Thermo Fisher Scientific #Webinar

Webinar: Scaling up IVT in mRNA production

Join DDW for this exclusive free event, Scaling up in vitro transcription: Key results and considerations, which is supported by Thermo Fisher Scientific. In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that… Read More

#News

Two scientists working in a research laboratory
#In vitro #IVT #mRNA #Thermo Fisher Scientific #Webinar

Understand the key considerations for scaling up in vitro transcription

Join DDW for this exclusive free event, Scaling up in vitro transcription: Key results and considerations, which is supported by Thermo Fisher Scientific. In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that… Read More

#News

#Drug development #Drug discovery #Gene therapy #Genetics / genomics #mRNA

New DDW Highlights podcast: 10 October 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  In celebration of the Nobel Prize for Medicine going to two of… Read More

#News

Scientists in medical research lab
#In vitro #IVT #mRNA #Thermo Fisher Scientific #Webinar

Exclusive event: Scaling up in vitro transcription

Join DDW for this exclusive free event, Scaling up in vitro transcription: Key results and considerations, which is supported by Thermo Fisher Scientific. In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that… Read More

#News

#Drug development #Drug discovery #Gene therapy #Genetics / genomics #mRNA

This week in drug discovery (2-6 October)  

News round-up for 2-6 October by DDW Digital Content Editor Diana Spencer. In celebration of the Nobel Prize for Medicine going to two of the early proponents of mRNA technology for creating therapeutics, Katalin Karikó and Drew Weissman, this week our round-up highlights the importance of… Read More

#News

Katalin Karikó and Drew Weissman
#Covid-19 vaccine #Karolinska Institutet #mRNA #mRNA-based vaccines #Nobel Prize

mRNA pioneers Katalin Karikó and Drew Weissman receive Nobel prize

The Nobel Assembly at Karolinska Institutet has awarded the 2023 Nobel Prize in Physiology or Medicine jointly to Katalin Karikó and Drew Weissman for their discoveries that enabled the development of mRNA vaccines against Covid-19. In a statement, the Assembly said: “The discoveries by the two… Read More

#News #Trending News

Scientific research
#In vitro #IVT #mRNA #Thermo Fisher Scientific #Webinar

Scaling up in vitro transcription: webinar

Join DDW for this exclusive free event, Scaling up in vitro transcription: Key results and considerations, which is supported by Thermo Fisher Scientific. In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that… Read More

#News

Scientific research
#Drug discovery #In vitro #mRNA #Webinar

Scaling up in vitro transcription: Key results and considerations

In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that need to be optimised and controlled to give the best result in terms of mRNA yields and quality. In this presentation, a review of the results from scaling… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#Webinars

Doctor prepares vaccine
#Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines #Phase I trial #Rabies #Replicate Bioscience #srRNA

Phase I trial of next-generation srRNA rabies vaccine

Replicate Bioscience has dosed the first participant in a Phase I trial of its RBI-4000 vaccine for the prevention of rabies. The trial, which marks the first time a human has been dosed with Replicate’s srRNA technology, will serve as a benchmark for utility in this… Read More

#News

microRNA
#App note #Drug development #Drug discovery #mRNA #Purification technology #Screening

App Note: Achieve mRNA binding with DBC values over 6mg/mL

A new Application Note is now available to download from Sartorius BIA Separations. In this App Note, multi-parallel screening of binding conditions on CIM Oligo dT 96-well plates was performed to optimise the dynamic binding capacity (DBC) in the shortest time possible. What you will learn: How to effectively use Monolithic 96-well plates… Read More

#News

#Drug development #Drug discovery #mRNA #Purification technology #Screening

Discover how to achieve mRNA binding on Oligo dT with DBC values over 6mg/mL

In this Application Note, multi-parallel screening of binding conditions on CIM® Oligo dT 96-well plates was performed to optimise the dynamic binding capacity (DBC) in the shortest time possible. What you will learn: How to effectively use Monolithic 96-well plates when developing methods. They are unique on the market in combining the… Read More

#Resources

Cancer cells
#Bispecific therapeutics #Cancer research #Collaboration #Drug development #Immatics #Moderna #mRNA

Multi-platform collab to develop innovative oncology therapeutics 

Moderna and Immatics have announced a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high, unmet medical need.   This broad multi-platform collaboration will leverage the scientific expertise and core operational capabilities of both companies, combining Immatics’ TCR platform with Moderna’s… Read More

#Cancer Research #News

Genetic engineering RNA
#Antisense Oligonucleotides (ASOs) #circular RNAs #Immunology / Virology & Vaccines #mRNA #RNA sequencing #siRNA

World RNA Day: What impact has RNA had on drug discovery?  

1 August was first chosen as World RNA Day in 2018 as a play on AUG (adenine, uracil and guanine), a triple sequence of RNA (called a codon) that initiates protein synthesis by the cell. Since then, it has been observed to publicise the importance of this molecule in the… Read More

#Exclusive Content